BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Joo I, Kim HC, Kim GM, Paeng JC. Imaging Evaluation Following 90Y Radioembolization of Liver Tumors: What Radiologists Should Know. Korean J Radiol 2018;19:209-22. [PMID: 29520178 DOI: 10.3348/kjr.2018.19.2.209] [Cited by in Crossref: 17] [Cited by in F6Publishing: 12] [Article Influence: 4.3] [Reference Citation Analysis]
Number Citing Articles
1 Filippi L, Schillaci O, Cianni R, Bagni O. Imaging Neuroendocrine Hepatic Metastases Following 90Y-Radioembolization: Is It Time to Implement Routine Use of PET Molecular/Metabolic Probes? Cardiovasc Intervent Radiol 2019;42:933-4. [PMID: 30783781 DOI: 10.1007/s00270-019-02186-w] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
2 Triviño-Ibáñez EM, Pardo Moreno P, Ciampi Dopazo JJ, Ramos-Font C, Ruiz Villaverde G, González-Flores E, Navarro Vergara PF, Rashki M, Gómez-Río M, Rodríguez-Fernández A. Biomarkers associated with survival and favourable outcome of radioembolization with yttrium-90 glass microspheres for colon cancer liver metastases: Single centre experience. Rev Esp Med Nucl Imagen Mol (Engl Ed) 2021:S2253-8089(21)00128-2. [PMID: 34454892 DOI: 10.1016/j.remnie.2021.08.001] [Reference Citation Analysis]
3 Kubik A, Budzyńska A, Kacperski K, Maciak M, Kuć M, Piasecki P, Wiliński M, Konior M, Dziuk M, Iller E. Evaluation of qualitative and quantitative data of Y-90 imaging in SPECT/CT and PET/CT phantom studies. PLoS One 2021;16:e0246848. [PMID: 33566845 DOI: 10.1371/journal.pone.0246848] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Koh DM, Ba-Ssalamah A, Brancatelli G, Fananapazir G, Fiel MI, Goshima S, Ju SH, Kartalis N, Kudo M, Lee JM, Murakami T, Seidensticker M, Sirlin CB, Tan CH, Wang J, Yoon JH, Zeng M, Zhou J, Taouli B. Consensus report from the 9th International Forum for Liver Magnetic Resonance Imaging: applications of gadoxetic acid-enhanced imaging. Eur Radiol 2021;31:5615-28. [PMID: 33523304 DOI: 10.1007/s00330-020-07637-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Filippi L, Cianni R, Schillaci O, Bagni O. Molecular and Metabolic Imaging of Hepatic Neuroendocrine Tumors Following Radioembolization with 90Y-microspheres. Curr Med Imaging 2020;16:545-52. [PMID: 32484088 DOI: 10.2174/1573405615666190114150038] [Reference Citation Analysis]
6 Tudela-lerma M, Orcajo-rincón J, Ramón-botella E, Álvarez-luque A, Gonzalez-leyte M, Rotger-regi A, Velasco-sánchez E, Colón-rodriguez A. Efficacy and safety of Yttrium-90 radioembolization in the treatment of neuroendocrine liver metastases. Long-term monitoring and impact on survival. Revista Española de Medicina Nuclear e Imagen Molecular (English Edition) 2021;40:82-90. [DOI: 10.1016/j.remnie.2021.01.009] [Reference Citation Analysis]
7 Kim HC, Lee M, Lee JH, Paeng JC, Kim YJ, Chung JW. Combination of 1st and 2nd Week Dosing of Glass Yttrium-90 Microspheres for Superselective Radioembolization. In Vivo 2020;34:2763-8. [PMID: 32871812 DOI: 10.21873/invivo.12100] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
8 Hectors SJ, Lewis S, Kennedy P, Bane O, Said D, Segall M, Schwartz M, Kim E, Taouli B. Assessment of Hepatocellular Carcinoma Response to 90Y Radioembolization Using Dynamic Contrast Material-enhanced MRI and Intravoxel Incoherent Motion Diffusion-weighted Imaging. Radiol Imaging Cancer 2020;2:e190094. [PMID: 32803165 DOI: 10.1148/rycan.2020190094] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
9 Kim PH, Choi SH, Kim JH, Park SH. Comparison of Radioembolization and Sorafenib for the Treatment of Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis: A Systematic Review and Meta-Analysis of Safety and Efficacy. Korean J Radiol. 2019;20:385-398. [PMID: 30799569 DOI: 10.3348/kjr.2018.0496] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 4.3] [Reference Citation Analysis]
10 Kim HC, Choi JW, Lee M, Kim YJ, Paeng JC, Chung JW. Lung Shunt Reduction for Yttrium-90 Radioembolization: Chemoembolization Versus Radioembolization. In Vivo 2021;35:2305-12. [PMID: 34182510 DOI: 10.21873/invivo.12504] [Reference Citation Analysis]
11 Gregory J, Dioguardi Burgio M, Corrias G, Vilgrain V, Ronot M. Evaluation of liver tumour response by imaging. JHEP Rep 2020;2:100100. [PMID: 32514496 DOI: 10.1016/j.jhepr.2020.100100] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 7.0] [Reference Citation Analysis]
12 Alem Z, Murray TE, Egri C, Chung J, Liu D, Elsayes KM, Chang SD, Harris A. Treatment response assessment following transarterial radioembolization for hepatocellular carcinoma. Abdom Radiol (NY) 2021;46:3596-614. [PMID: 33909092 DOI: 10.1007/s00261-021-03095-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
13 Schobert I, Chapiro J, Nezami N, Hamm CA, Gebauer B, Lin M, Pollak J, Saperstein L, Schlachter T, Savic LJ. Quantitative Imaging Biomarkers for 90Y Distribution on Bremsstrahlung SPECT After Resin-Based Radioembolization. J Nucl Med 2019;60:1066-72. [PMID: 30655331 DOI: 10.2967/jnumed.118.219691] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
14 Tudela-Lerma M, Orcajo-Rincón J, Ramón-Botella E, Álvarez-Luque A, González-Leyte M, Rotger-Regi A, Velasco-Sánchez E, Colón-Rodríguez A. Efficacy and safety of Yttrium-90 radioembolization in the treatment of neuroendocrine liver metastases. Long-term monitoring and impact on survival. Rev Esp Med Nucl Imagen Mol (Engl Ed) 2021;40:82-90. [PMID: 33239249 DOI: 10.1016/j.remn.2020.09.002] [Reference Citation Analysis]
15 Kim BH. Selecting the Right Tool for the Right Job: Which Response Criteria Better Predicts Survival of Patients Treated with Transarterial Radioembolization? Gut Liver 2020;14:671-2. [PMID: 33191309 DOI: 10.5009/gnl20324] [Reference Citation Analysis]
16 Triviño-Ibáñez EM, Pardo Moreno P, Ciampi Dopazo JJ, Ramos-Font C, Ruiz Villaverde G, González-Flores E, Navarro Vergara PF, Rashki M, Gómez-Río M, Rodríguez-Fernández A. Biomarkers associated with survival and favourable outcome of radioembolization with yttrium-90 glass microspheres for colon cancer liver metastases: Single centre experience. Rev Esp Med Nucl Imagen Mol 2021:S2253-654X(21)00129-3. [PMID: 34294586 DOI: 10.1016/j.remn.2021.05.004] [Reference Citation Analysis]
17 Spieler B, Sabottke C, Moawad AW, Gabr AM, Bashir MR, Do RKG, Yaghmai V, Rozenberg R, Gerena M, Yacoub J, Elsayes KM. Artificial intelligence in assessment of hepatocellular carcinoma treatment response. Abdom Radiol (NY) 2021;46:3660-71. [PMID: 33786653 DOI: 10.1007/s00261-021-03056-1] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]